{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:33:39Z","timestamp":1775684019280,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Gestational weight gain above Institute of Medicine recommendations is associated with increased risk of pregnancy complications. The goal was to analyze the association between newer HIV antiretroviral regimens (ART) on gestational weight gain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective cohort study of pregnant women with HIV-1 on ART. The primary outcome was incidence of excess gestational weight gain. Treatment effects were estimated by ART regimen type using log-linear models for relative risk (RR), adjusting for prepregnancy BMI and presence of detectable viral load at baseline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Three hundred three pregnant women were included in the analysis. Baseline characteristics, including prepregnancy BMI, viral load at prenatal care entry, and gestational age at delivery were similar by ART, including 53% of the entire cohort had initiated ART before pregnancy (P\u2005=\u2005nonsignificant). Excess gestational weight gain occurred in 29% of the cohort. Compared with non\u2013integrase strand transfer inhibitor (-INSTI) or tenofovir alafenamide fumarate (TAF)\u2013exposed persons, receipt of INSTI+TAF showed a 1.7-fold increased RR of excess gestational weight gain (95% CI: 1.18\u20132.68; P\u2005&amp;lt;\u2005.01), while women who received tenofovir disoproxil fumarate had a 0.64-fold decreased RR (95% CI: .41\u2013.99; P\u2005=\u2005.047) of excess gestational weight gain. INSTI alone was not significantly associated with excess weight gain in this population. The effect of TAF without INSTI could not be inferred from our data. There was no difference in neonatal, obstetric, or maternal outcomes between the groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Pregnant women receiving ART with a combined regimen of INSTI and TAF have increased risk of excess gestational weight gain.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab994","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T20:21:40Z","timestamp":1638390100000},"page":"665-672","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Pregnancy on Gestational Weight Gain"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-1609","authenticated-orcid":false,"given":"Naima T","family":"Joseph","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen A","family":"Satten","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E","family":"Williams","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine, State University at New York , Buffalo, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa B","family":"Haddad","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, Population Council , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J","family":"Jamieson","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anandi N","family":"Sheth","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina L","family":"Badell","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2022091018192489000_CIT0001","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/jac\/dky145","article-title":"Obesity following ART initiation is common and influenced by both traditional and HIV-\/ART-specific risk factors.","volume":"73","author":"Bakal","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2022091018192489000_CIT0002","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/cid\/civ192","article-title":"Weight change after antiretroviral therapy and mortality.","volume":"60","author":"Yuh","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022091018192489000_CIT0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada.","volume":"32","author":"Koethe","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022091018192489000_CIT0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/hiv.12294","article-title":"Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.","volume":"17","author":"Achhra","year":"2016","journal-title":"HIV Med"},{"key":"2022091018192489000_CIT0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00126334-200303010-00009","article-title":"Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.","volume":"32","author":"Justman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022091018192489000_CIT0006","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/QAI.0b013e31827303d5","article-title":"Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering.","volume":"61","author":"Kim","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022091018192489000_CIT0007","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/QAD.0000000000001817","article-title":"A week-48 randomized phase-3 trial of darunavir\/cobicistat\/emtricitabine\/tenofovir alafenamide in treatment-naive HIV-1 patients.","volume":"32","author":"Eron","year":"2018","journal-title":"AIDS"},{"key":"2022091018192489000_CIT0008","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3018(16)30091-1","article-title":"Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis.","volume":"3","author":"Kanters","year":"2016","journal-title":"Lancet HIV"},{"key":"2022091018192489000_CIT0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0160087","article-title":"Therapy-emergent drug resistance to integrase strand transfer inhibitors in HIV-1 patients: a subgroup meta-analysis of clinical trials.","volume":"11","author":"You","year":"2016","journal-title":"PLoS One"},{"key":"2022091018192489000_CIT0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/AOG.0000000000003114","article-title":"Gestational weight gain and severe maternal morbidity at delivery hospitalization.","volume":"133","author":"Platner","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2022091018192489000_CIT0011","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.annepidem.2020.06.009","article-title":"Excessive gestational weight gain is associated with severe maternal morbidity.","volume":"50","author":"Freese","year":"2020","journal-title":"Ann Epidemiol"},{"key":"2022091018192489000_CIT0012","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrendo.2012.96","article-title":"Gestational diabetes mellitus: risks and management during and after pregnancy.","volume":"8","author":"Buchanan","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"2022091018192489000_CIT0013","article-title":"Diagnoses of HIV infection in the United States and dependent areas.","volume-title":"HIV Surveill Rep","author":"Centers for Disease Control and Prevention.","year":"2019"},{"key":"2022091018192489000_CIT0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofz183","article-title":"Improved perinatal and postpartum human immunodeficiency virus outcomes after use of a perinatal care coordination team.","volume":"6","author":"Hackett","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022091018192489000_CIT0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/AOG.0000000000002638","article-title":"What obstetrician-gynecologists should know about population health.","volume":"131","author":"Jamieson","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2022091018192489000_CIT0016","first-page":"i-253","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation.","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2022091018192489000_CIT0017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/AOG.0000000000002042","article-title":"Committee opinion no. 700 summary: methods for estimating the due date.","volume":"129","author":"Goldberg","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2022091018192489000_CIT0018","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A Modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2022091018192489000_CIT0019","first-page":"41","article-title":"Are new antiretroviral treatments increasing the risks of clinical obesity?","volume-title":"J Virus Erad","author":"Hill","year":"2019"},{"key":"2022091018192489000_CIT0020","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment na\u00efve persons starting dolutegravir-based antiretroviral therapy.","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022091018192489000_CIT0021","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","article-title":"Weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens.","volume":"76","author":"Norwood","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022091018192489000_CIT0022","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMoa1904340","article-title":"Dolutegravir-based or low-dose efavirenz-based regimen for the treatment of HIV-1.","volume":"381","author":"Kouanfack","year":"2019","journal-title":"N Engl J Med"},{"key":"2022091018192489000_CIT0023","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV.","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"key":"2022091018192489000_CIT0024","author":"World Health Organization.","year":"2019"},{"key":"2022091018192489000_CIT0025","article-title":"Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States.","author":"Department of Health and Human Services, Panel on Treatment of Pregnant Women with HIV Infection.","year":"2020"},{"key":"2022091018192489000_CIT0026","doi-asserted-by":"crossref","first-page":"100615","DOI":"10.1016\/j.eclinm.2020.100615","article-title":"Weight gain during pregnancy among women initiating dolutegravir in Botswana.","volume":"29\u201330","author":"Caniglia","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2022091018192489000_CIT0027","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000003584","article-title":"Combination antiretroviral therapy and hypertensive disorders of pregnancy.","volume":"134","author":"Saums","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2022091018192489000_CIT0028","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/aje\/kwaa135","article-title":"Hypertensive disorders of pregnancy, cesarean delivery, and severe maternal morbidity in an urban safety-net population.","volume":"189","author":"Boulet","year":"2020","journal-title":"Am J Epidemiol"},{"key":"2022091018192489000_CIT0029","doi-asserted-by":"publisher","first-page":"S0002-9378(20)31128-5","DOI":"10.1016\/j.ajog.2020.09.037","article-title":"Eclampsia in the 21st century.","author":"Fishel Bartal","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2022091018192489000_CIT0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jinf.2013.12.018","article-title":"Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries.","volume":"68","author":"Machado","year":"2014","journal-title":"J Infect"},{"key":"2022091018192489000_CIT0031","doi-asserted-by":"crossref","first-page":"643.e1","DOI":"10.1016\/j.ajog.2015.11.004","article-title":"Measuring severe maternal morbidity: validation of potential measures.","volume":"214","author":"Main","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022091018192489000_CIT0032","doi-asserted-by":"publisher","first-page":"e038187","DOI":"10.1136\/bmjopen-2020-038187","article-title":"Gestational weight gain and adverse pregnancy outcomes: a prospective cohort study.","author":"Wu","year":"2020"},{"key":"2022091018192489000_CIT0033","doi-asserted-by":"publisher","first-page":"e61627","DOI":"10.1371\/journal.pone.0061627","article-title":"Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight\/obesity: a systematic review and meta-analysis.","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"2022091018192489000_CIT0034","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000508036","article-title":"Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: a systematic review and meta-analysis.","volume":"145","author":"Wu","year":"2020","journal-title":"Cardiology"},{"key":"2022091018192489000_CIT0035","volume-title":"Strategies to reduce pregnancy-related deaths: from identification and review to action","author":"Berg","year":"2001"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab994\/41989175\/ciab994.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/4\/665\/45787144\/ciab994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/4\/665\/45787144\/ciab994.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T18:21:27Z","timestamp":1662834087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/4\/665\/6448917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,3]]},"published-print":{"date-parts":[[2022,9,10]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab994","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,15]]},"published":{"date-parts":[[2021,12,3]]}}}